Skip to main content
Clinical Trials/NCT05699096
NCT05699096RecruitingNot Applicable

Perfluorooctyl Bromideessential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

EL Romany Ophthalmics Factory1 site in 1 country20 target enrollmentStarted: September 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
flat the detached retina and displace the underneath fluids anteriorly

Study Overview

Brief Summary

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • - Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing;

Exclusion Criteria

  • Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

Outcomes

Primary Outcomes

flat the detached retina and displace the underneath fluids anteriorly

Time Frame: Base line

the effect of Perfluorooctyl Bromide on the retina ,under ophthalmic microscope check the flatted retina

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
EL Romany Ophthalmics Factory
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials